Skip to content

Combination of traditional Chinese and western medicine combined with gancao nurish-yin decorction in the treatment of senile rheumatoid arthritis:clinical real world study

Combination of traditional Chinese and western medicine combined with gancao nurish-yin decorction in the treatment of senile rheumatoid arthritis:clinical real world study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400086304
Enrollment
Unknown
Registered
2024-06-28
Start date
2024-07-01
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid arthritis

Interventions

Intervention group (Western medicine conventional treatment based on the addition of licorice yin nourishing soup):NA

Sponsors

Affiliated Hospital of Zunyi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) Meet the 2010 ACR/EULAR diagnostic criteria for the classification of rheumatoid arthritis; 2) age greater than 60 years; autonomous social behavior, voluntary enrollment in the study, and ability to sign informed consent.

Exclusion criteria

Exclusion criteria: 1) Serious comorbidities such as interstitial pneumonia, pulmonary hypertension, rheumatoid malignancy, or complications of other major diseases,for example: progressive cancer, diabetic ketoacidosis, hyperglycemic hyperosmolar state, hypertension grade 3 or high risk group, heart attack or stroke episode; 2) active infections, e.g., hepatitis B, tuberculosis, AIDS, etc; 3) less than 3 months after surgery or during radiotherapy; 4) patients with a combination of other diseases resulting in an expected survival of less than 1 year; 5) patients with mental disorders, unable to cooperate.

Design outcomes

Primary

MeasureTime frame
Erythrocyte sedimentation rate;C-reactive protein;rheumatoid factor;Disease Activity Score28-Erythrocyte sedimentation rate;Short Form-36;

Secondary

MeasureTime frame
Body Mass Index;blood pressure;routine blood test;blood lipids;blood glucose;Liver function;kidney function;tumor marker;biological age;inflammatory factor;Carotid artery middle layer intima-media thickness;Bone mineral density;Chest high resolution CT;Pulmonary function;

Countries

China

Contacts

Public ContactYong Chen

Affiliated Hospital of Zunyi Medical University

sgcy88888888@qq.com+86 183 2111 6879

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026